G

Glympse Bio

22 employees

Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.

Basic info

Industry

medical equipment manufacturing

Sectors

Biotechnology
Medical Device
Health Care
Nanotechnology
Life Science

Date founded

2015

Funding rounds raised

Total raised

$47M

from 18 investors over 18 rounds

G

Glympse Bio raised $47M on July 15, 2020

Investors: New Leaf Venture Partners, GreatPoint Ventures, DNS Capital, Section 32, Temasek, CRV, Catalio Capital Management, ARCH Venture Partners and Gilead Sciences

G

Glympse Bio raised $22M on October 9, 2018

Investors: Heritage Physician Networks, 上海涌铧投资管理有限公司, Inevitable Ventures, CRV, Gilead Sciences, GreatPoint Ventures and ARCH Venture Partners

G

Glympse Bio raised $6.6M on December 1, 2015

Investors: Aspect Ventures and Biocon

FAQ